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Objective: Maternal depressive symptoms during pregnancy have been associated with poor 
offspring sleep. Yet, it remains unknown whether depressive symptoms throughout pregnancy are 
more harmful to the child than depressive symptoms nly during certain time periods in pregnancy, 
whether associations are specific to pregnancy stage, whether maternal symptomatology after 
pregnancy mediates or adds to the prenatal effects, and whether any effects are specific to some 
child sleep characteristics.  
Methods: A total of 2321 mothers from the Prediction and Prevention of Pre-eclampsia and 
Intrauterine Growth Restriction (PREDO) study completed the Center for Epidemiological Studies 
Depression Scale biweekly between gestational weeks+days 12+0/13+6 and 38+0/39+6. At child’s 
mean age of 3.5 (standard deviation = 0.7) years, mothers completed the Beck Depression 
Inventory−II and answered questions on child sleep quantity and quality using the Brief Infant 
Sleep Questionnaire and sleep disorders using the Sleep Disturbance Scale for Children.  
Results: Maternal depressive symptoms showed high stability throughout pregnancy. Children of 
mothers with clinically significant symptomatology throughout pregnancy had shorter mother-rated 
sleep duration, longer sleep latency, higher odds for waking up two or more times during the night 
and for total and several specific sleep disorders. These associations were robust to covariates. 
However, maternal depressive symptoms at the child follow-up fully mediated the associations with 
sleep duration and awakenings, partially mediated those with sleep latency and disorders, and added 
to the effects on sleep disorders.  
Conclusion: Maternal depressive symptoms throughout pregnancy re associated with mother-rated 
child sleep quantity, quality, and disorders. Maternal depressive symptoms at child follow-up 

















Insufficient sleep quantity, poor sleep quality, and sleep disorders, such as difficulty initiating and 
maintaining sleep, sleep breathing disorders, and nightmares, are common concerns in children. It 
has been estimated that such concerns affect up to 76% of school-aged children, with 4% of 
children aged 0−18 years with a diagnosed sleep disorder [1−4]. These problems tend to persist into 
adolescence [5] and even into adulthood [6,7]. Because insufficient sleep quantity, poor sleep 
quality, and sleep disorders not only increase an individual’s obesity and insulin resistance [8−13] 
and risk for a variety of physical and mental disorders [14], but also hinder one’s quality of life, 
cognitive, emotional, and social functioning and academic performance [15−17], it is especially 
important to identify factors, as early in life as possible, that may render an individual vulnerable to 
sleep problems.  
 
One key early life risk factor is maternal depressive symptoms during pregnancy. Emerging 
evidence suggests that although pregnancy in itselfnduces alterations in physiological homeostasis, 
these alterations may be aggravated in depressive states. The alterations include changes in the 
hypothalamic−pituitary−adrenocortical axis, inflammatory and autonomic nervous system 
functioning, and in oxidative stress and nutrition levels [18−25]. These depression-related changes 
may alter the development of fetal cells, tissues and organs, their structure and functioning, the set 
points of body’s chrono-biological systems, and increase the risk for adverse programmed 
phenotypes in the offspring that will persist throughout the lifespan [24,26] Indeed, a series of 
studies have shown that maternal depressive symptoms during pregnancy are associated with sleep 
quantity and quality and sleep disorders of the offspring in childhood [27−33]. In one of the largest 
of these studies that reported findings from both the Avon Longitudinal Study of Parents and 
Children (ALSPAC) and the Generation R, maternal depressive symptoms measured at 32 















with shorter sleep duration and higher number of nightt me awakenings in children at the age of 18 
and 20 months [30]. In another large-scale study reporting findings from the project VIVA, 
maternal depressive symptoms during pregnancy were associated with the child’s shorter sleep 
duration at ages 1 and 2 years [31]. Yet, another study using the ALSPAC data demonstrated that 
maternal depressive symptoms measured at 18 and 32 weeks of gestation were not associated with 
sleep duration or number of nighttime awakenings when t e child was 6, 18, or 30 months of age 
but were associated with a total sleep problems score when the child was 18 and 30 months of age 
[32]. 
 
The existing studies have, however, typically relied on one or two measurements of maternal 
depressive symptoms during pregnancy. Hence, it remains unclear whether depressive symptoms 
throughout pregnancy carry more harmful effects to the child than depressive symptoms only 
during specific time periods. Moreover, the studies have not accounted for maternal depressive 
symptoms at the time of rating the child sleep, which in fact may bias the mother’s report of child 
sleep. Thus, it remains unclear whether any potential associations between maternal depressive 
symptoms and child sleep are specific to the prenatal stage, and whether maternal depressive 
symptoms at the time of rating the child add to the prenatal effects. Finally, it remains unclear 
whether maternal depressive symptoms during pregnancy re associated with specific sleep 
problems or whether the associations generalize to all domains of sleep. Further specificity into 
these associations may afford the development of more targeted and personalized preventive 
interventions.  
 
To address these caveats in the literature, we testd, in a large prospective pregnancy cohort of 2321 















during pregnancy starting from gestational week 12−13 were associated with their 3.5-year-old 
child’s mother-rated nocturnal sleep duration, nightt me awakenings and sleep latency, and 
disorders of initiating and maintaining sleep, sleep breathing disorders, arousal disorders, 
sleep−wake transition disorders, disorders of excessiv  somnolence, and sleep hyperhidrosis. Our 
repeated-measures study design allowed us to test whether maternal depressive symptoms at some 
stages or throughout pregnancy carried harmful effects on child sleep. Finally, we also tested 
whether maternal depressive symptoms at the time of rating the child`s sleep accounted for, 


















The participants come from the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth 
Restriction (PREDO) study. The study design is described in the cohort profile [34]. A total of 4785 
pregnant women were recruited in arrival order when t y attended the first ultrasound screening at 
12+0−13+6 weeks+days of gestation in 1 of the 10 hospital maternity clinics in southern and 
eastern Finland. Of them, 4777 gave birth to a singleton live child between 2006 and 2010. Of these 
women, 3400 (71.2% of those with live-born offspring) filled in the biweekly depressive symptoms 
questionnaire during pregnancy. 
 
In 2011−2012, a total of 4585 women and their children of the original sample were invited for a 
follow-up (three children had died after birth or before the follow-up, 33 did not have data in 
Finnish nationwide Medical Birth Register, 56 women had declined participation in a follow-up, 
and for 100 women, addresses were not traceable), which included a survey on maternal depressive 
symptoms and child sleep. Of the invited women and children, 2667 (58.2%) participated. 
 
Of the 2667 women and children with follow-up data, 2620 had data available on mother-rated 
child sleep at the follow-up, and 2321 had data avail ble on both antenatal depression and child 
sleep. The current study sample thus comprises these 2321 women and their on-average 3.5-year-
old children (SD = 0.7, range 1.9−5.9) (1177 boys, 1144 girls; 68.3% of those with data on 
depressive symptoms during pregnancy). 
 
Compared to the women who were invited but did not par icipate to the follow-up study, those who 
participated were older (mean age 31.9 vs 31.1 years, SD = 4.6 vs 5.1, p < 0.001), had lower early-















throughout pregnancy (2.8% vs7.5%, p < 0.001), were less likely to have a primary or secondary 
education only (37.3% vs 46.0%, p < 0.001), were more likely to have an upper tertiary education 
(35.7% vs 29.3%, p<.001), and were more likely to be primiparous (42.0% vs 35.5%, p < 0.001), 
and their children were more likely to be girls (49.3% vs 46.4%, p = 0.049). They did not differ in 
hypertensive or diabetic pregnancy disorders or depessive symptom scores during pregnancy, and 
their children did not differ in length of gestation, birth anthropometry, or other perinatal 
characteristics.  
 
The PREDO study protocol was approved by the Ethics Committee of Obstetrics and Gynecology 
and Women, Children and Psychiatry of the Helsinki and Uusimaa Hospital District and by the 
participating hospitals. All participants provided written informed consent. Consent of participating 
children was provided by parent(s) or guardian(s).  
 
2.2. Maternal depressive symptoms 
Starting from gestation weeks+days 12+0−13+6, and at 2-week intervals up to delivery or gestation 
weeks+days 38+0−39+6, the women filled in the Center for Epidemiological Studies Depression 
Scale (CES-D) [35]. The scale comprises 20 questions on frequency of depressive symptoms during 
the past 7 days, rated on a scale from none of the time (0) to all of the time (3). The total CES-D 
sum score is calculated as the sum of responses to all 20 questions (range 0−60), with the higher 
score indicating more frequent depressive symptomatlogy. The cutoff score of 16 or greater 
identifies individuals at risk for clinically relevant depression.  
 
In addition, at the time of rating the child sleep, the mothers completed the Beck Depression 















previous 2 weeks. Each item contains four statements, rated from 0 to 3, reflecting increasing 
degrees of symptom severity [36]. The total BDI-II sum score is calculated as the sum of the 
responses to all 21 questions (range 0−63), with hig er scores indicating more severe depressive 
symptomatology. 
 
Both the CES-D and the BDI-II have good psychometric p operties [35−39] and the CES-D has 
been used extensively and validated also in pregnant populations [38]. In our sample, the CES-D 
(Cronbach’s α =0.88−0.92 in the 14 biweekly measurement points) and the BDI-II (α = 0.90) 
showed high internal consistency.  
 
2.3.  Child sleep quantity, quality, and disorders  
We used three questions from the mother-rated Brief Infant Sleep Questionnaire (BISQ) to measure 
child’s nocturnal sleep duration (hours), latency to falling asleep for the night (minutes), and 
number of nighttime awakenings (categorized as none, , two or more times) during the previous 
week. These questions have good test−retest reliability and discriminant validity between clinical 
and nonclinical groups [40].  
 
The Sleep Disturbance Scale for Children (SDSC) [41] comprises 26 items measuring child sleep-
related behaviors and disturbances during the previous 6 months. The items are rated on a scale 
ranging from 1 (never) to 5 (always−daily). In addition to a total sleep disorders score, the SDSC 
yields scores for six sleep disorder subscales, namely disorders of initiating and maintaining sleep, 
sleep breathing disorders, disorders of arousal (sleepwalking, sleep terrors, nightmares), 
sleep−wake transition disorders (hypnic jerks, rhythmic movement disorders, hypnagogic 















hyperhidrosis. Those reporting the closest score to the 85th percentile cut-off score for a given 
subscale were identified as having sleep disorders. The SDSC scale has good internal consistency 
and validity [42−44].  
 
2.4.  Covariates 
These included the following maternal characteristics: age at delivery (years), early-pregnancy body 
mass index (BMI; kg/m2), parity (primiparous/multiparous) and smoking during pregnancy (no/quit 
during first trimester/smoked throughout pregnancy), and hypertensive (gestational hypertension, 
preeclampsia, chronic hypertension) and diabetic (gestational diabetes, type 1 diabetes; no women 
had type 2 diabetes) pregnancy disorders derived from the Finnish Medical Birth Register (MBR). 
For a subsample, diabetic and hypertensive disorders w e verified by a clinical jury. Maternal 
education (primary or secondary/lower tertiary/upper tertiary) and alcohol use during pregnancy 
(yes/no) were self-reported in early pregnancy. Child characteristics included as covariates were 
child’s sex (girl/boy), gestational age (weeks), and weight (kg) at birth, and at the follow-up child’s 
age and weight-for-height SD score specific for the c ild’s age and sex according to Finnish growth 
charts [45] derived from the child’s welfare clinic records. We also accounted for the child’s 
psychiatric symptoms rated by the mothers using the C ild Behavior Checklist 1½−5 (CBCL 1½−5) 
[46] parallel to rating the child sleep. 
 
2.5.  Statistical analyses 
We first examined maternal depressive symptoms profiles during pregnancy with a latent profile 
analysis. Latent profile analysis is a technique to identify a number of distinct, fully comprehensive, 
and nonoverlapping latent classes of individuals based on individual responses to a set of 















of depressive symptoms across pregnancy. Our study with 14 assessments of maternal antenatal 
depressive symptoms among more than 2000 participants is well suited for latent profile analyses 
[47]. We compared solutions with one to nine clusters, and identified the most optimal one by using 
Akaike Information Criterion, sample size−adjusted Bayesian Information Criterion, and 
Vuong−Lo−Mendell−Rubin likelihood ratio test and Lo−Mendell−Rubin−adjusted likelihood ratio 
tests. By using linear (sleep duration and latency), multinomial (nighttime awakenings) and logistic 
regression analyses (sleep disorders), we then compared child sleep characteristics between the 
maternal latent profile groups. These group differences are presented as mean differences (MD) and 
odds ratios (OR) and their 95% confidence intervals (CI).  
 
All the analyses were adjusted for child’s age and sex. We thereafter made adjustments for maternal 
age, education, parity, early pregnancy BMI, pregnancy and pre-pregnancy disorders, smoking and 
alcohol use, and child’s gestational age and birth weight (model b). 
 
Because child anthropometric measures at the time of rating the sleep were available only for a 
subsample of participants (n = 1869), child weight-for-height SD score specific for the child’s age 
and sex according to Finnish growth charts [45] wasadded to the covariates in a separate model 
(model c). 
 
To account for maternal depressive symptoms at the time of rating the child sleep, maternal 
symptoms variable at the child follow-up was added into the regression models, together with 
















To account for child’s psychiatric symptoms at the time of child sleep assessment, we conducted 
sensitivity analyses by excluding children who displayed borderline significant total behavior 
problems (T-score at or above 65) in the CBCL from the analyses.  
 
To test whether the associations between maternal depressive symptoms during pregnancy and child 
sleep were trimester-specific, we conducted additional regression analyses in which we used 
maternal trimester-specific mean depressive symptoms scores (only one value at first trimester, 
mean of values between 14 and 24 and between 26 and 40 gestational weeks for the second and 
third trimesters, respectively) as predictor variables.  
 
Next, to study whether maternal depressive symptoms at the time of rating the child sleep mediated 
the effects of maternal depressive symptoms during pre nancy, we used mediation analysis using 
the PROCESS Macro 2.16.3 (www.processmacro.org) [48] for SPSS with 5000 bootstrapped 
samples. In these interaction and mediation analyses, w  used maternal trimester-weighted (mean of 
trimester-specific values) mean depressive symptoms score as the pregnancy stage variable. Finally, 
an interaction term of maternal depressive symptoms during pregnancy × maternal depressive 
symptoms at child follow-up entered together with their main effects tested whether maternal 
depressive symptoms at the time of rating child sleep added to the effects of maternal depressive 
symptoms during pregnancy.  
 
To facilitate the interpretation, continuous outcome variables, predictors, and covariates were 
standardized to the mean of 0 and standard deviation (SD) of 1. In all the analyses, two-tailed p 
values of <0.05 were considered significant. The analyses were conducted using IBM SPSS 































Characteristics of the sample are shown in Table 1. Maternal biweekly, trimester-specific, and 
trimester-weighted mean values of depressive symptos during pregnancy were significantly 
correlated (Pearson r = 0.45−0.96, all p < 0.001) and were also significantly correlated with 
depressive symptoms after pregnancy (Pearson r = 0.32−0.44, all p < 0.001). The median number of 
consecutive depressive symptom measurements during pregnancy in the entire sample was 13 and 
the interquartile range was 12−14. There were altogether 1131 women (48.7%) with data on all 14 
measurement points during pregnancy, and only 472 women (20.3%) had more than two missing 
values during pregnancy.  
 
Of the 1463 (63.1%) children with any of the sleep disorders, 675 (46.1%) had one, 389 (26.6%) 
had two, 221 (15.1%) had three, and 178 (12.2%) had four to six sleep disorders. The six sleep 
disorder scores were moderately intercorrelated (Pearson r = 0.11−0.37, all p < 0.001); Pearson r 
between disorders of initiating and maintaining sleep, sleep breathing disorders, arousal disorders, 
sleep−wake transition disorders, disorders of excessiv  somnolence and sleep hyperhidrosis with 
total sleep problems score were 0.76, 0.39, 0.52, 0.74, .62, and 0.46, respectively (all p < 0.001). 
Table S1 shows associations between covariates and child sleep quantity, quality, and sleep 
disorders.  
 
3.1. Associations between maternal depressive symptoms during pregnancy and child 
sleep quantity, sleep quality, and sleep disorders 
Latent profile analysis shows that the most optimal latent profile solution (in comparison to 
solutions with one to nine groups) identified three groups of women with consistently low (n = 
1075), subthreshold (n = 963), and clinically significant (n = 283) levels of depressive symptoms 















Information Criterion = 186911.2, Vuong−Lo−Mendell−Rubin likelihood ratio test, and 
Lo−Mendell−Rubin−adjusted likelihood ratio test p values = 0.02 and 0.03, respectively) (Fig. 1). 
 
Compared to children of women with consistently lowdepressive symptoms during pregnancy, 
children of women with clinically significant symptomatology throughout pregnancy had shorter 
sleep duration (Table 2), longer sleep latency (Table 2), and higher odds of waking up two or more 
times during the night (Fig. 2). All of these associations survived covariate adjustment, including 
adjustment for child weight-for-height SD score. In contrast to the other associations that were also 
independent of maternal depressive symptoms concurrently with child sleep ratings (Table 2, Fig. 
2), the association with sleep duration did not survive adjustments for maternal depressive 
symptoms parallel to rating the child sleep (Fig. 2). Children of women with subthreshold 
symptomatology also had longer sleep latency across all adjustment models, including adjustment 
for maternal depressive symptoms parallel to rating the child sleep (Table 2). Figure 3 shows that in 
comparison to children of women with low depressive symptoms during pregnancy, children of 
women with clinically significant symptomatology had higher odds for having total sleep disorders, 
and disorders of initiating and maintaining sleep, sleep breathing disorders, arousal disorders, 
sleep−wake transition disorders, excessive somnolence disorders, and sleep hyperhidrosis disorders. 
All of these associations survived for covariate adjustments, and when adjusted for child weight-
for-height SD score or maternal depressive symptoms parallel to rating the child sleep only, the 
association with sleep breathing disorders was rendered nonsignificant. In addition, children of 
women with subthreshold depressive symptoms during pre nancy had higher odds for total sleep 
disorders and for all the subscale disorders (Fig. 3). These associations also survived for covariate 
adjustments and adjustments for maternal depressive ymptoms parallel to rating the child sleep, 















for arousal, sleep−wake transition and sleep hyperhidrosis disorders were rendered nonsignificant 
(Fig. 3). 
 
None of the findings changed when we conducted sensitivity analyses and excluded the 183 
children with borderline clinically significant total behavior problems from the analyses (all p < 
0.05). 
 
Table S2 shows that when we used maternal trimester-specific depressive symptoms values as 
predictor variables, all the significant associations identified in the latent profile analyses were 
significant regardless of the pregnancy trimester.  
 
3.2. Mediating effects of maternal depressive symptoms at the time of rating the child sleep 
Figure S1 shows that although maternal depressive symptoms during pregnancy had a direct effect 
on child sleep latency (panel B) and total sleep disorders (panel D), maternal depressive symptoms 
at the time of rating the child sleep partially mediated these associations, and fully mediated the 
associations with nocturnal sleep duration (panel A) and nighttime awakenings (panel C). 
 
3.3.  Additive effects of maternal depressive symptoms at the time of rating the child sleep 
Interactions between maternal depressive symptoms during pregnancy × maternal depressive 
symptoms at the time of rating the child sleep were significant in the analyses of child sleep 
duration (p for interaction = 0.001 in model adjusted for covariates) and total sleep disorders (p for 
interaction < 0.001 in model adjusted for covariates). Figure 4 shows that maternal depressive 
symptoms parallel to rating the child did not add to the prenatal depressive symptoms effects on 
child sleep duration (panel A), but rather entirely accounted for the prenatal effects as sleep duration 















II ≥ 14) and both during pregnancy (CES-D ≥ 16) and at the time of rating the child sleep (BDI-II ≥ 
14) were the shortest. Maternal depressive symptoms parallel to rating the child, however, added to 
the maternal prenatal depression effects on child sleep disorders. Figure 4 (panel B) shows that the 
proportion with sleep disorders was the highest for children of mothers with clinically significant 

















Our study shows that maternal depressive symptoms throughout pregnancy are associated with 
shorter nocturnal sleep duration, longer sleep latency, higher odds of more frequent nighttime 
awakenings, and higher odds of total sleep disorders and disorders across all the measured sleep 
domains in the 3.5-year-old offspring. These associations were not pregnancy stage specific, as 
maternal depressive symptoms showed high stability throughout pregnancy, a finding that we have 
demonstrated in the PREDO study previously [49], and s the associations were significant when 
we used trimester-specific values of maternal depressiv  symptoms as predictors of child sleep 
characteristics. These associations were not accounted for by important covariates, including both 
maternal pregnancy and child perinatal characteristics, and not by child borderline clinically 
significant psychiatric problems either.  
 
Our study also shows that the prenatal depression effect on child sleep latency was not accounted 
for but partially mediated by maternal depressive symptoms parallel to rating the child sleep, that 
maternal depressive symptoms parallel to rating the child sleep partially mediated and added to the 
prenatal depression effects on child sleep disorders, and that the prenatal depression effect on child
nocturnal sleep duration and awakenings were accounted for by maternal depressive symptoms 
measured parallel to rating the child.  
 
Although our findings agree with the previous literature [27−29,31−33], they augment the literature 
also by showing that maternal depressive symptoms during and after pregnancy indicate widespread 
harms on child sleep characteristics. As maternal clinically relevant depressive symptoms both 
during and after pregnancy are common, with a 10% to 20% prevalence [50,51], and show high 















findings carry an important public health message: if the associations are causal, at least part of the 
sleep problems that concern a large pediatric population could be potentially prevented by effective 
treatment interventions that aim at alleviating maternal depression symptoms during pregnancy and 
preventing clinically significant symptoms. This is particularly important, because child sleep 
problems show high developmental stability and relate to psychological and physical health 
concerns. Moreover, poor child sleep was not limited to children of mothers with clinically relevant 
symptomatology, but also those with subthreshold symptomatology. This emphasizes the need of 
such preventive interventions even further.  
 
Our findings are also in agreement with the Developmental Origins of Health and Disease-concept 
[26]. However, the mechanisms underlying these associati ns remain to be elucidated. For example, 
fetal overexposure to maternal glucocorticoids and inflammatory cytokines may underlie these 
prenatal programming effects. Maternal depression and stress during pregnancy are associated with 
higher mRNA placenta levels of the glucocorticoid receptor (GR) and mineralocorticoid receptor 
(MR) [53], as well as raised plasma levels of cortitropin-releasing hormone (CRH), 
adrenocorticotropic hormone (ACTH), and cortisol [54]. High placental GR has been found to 
mediate the effects of maternal depressive symptoms on infant regulatory behavior, including 
sleeping behavior [22]. Animal studies have shown that prenatal stress induces a phase-shift in the 
offspring circadian rhythm for corticosterone secretion and a slower rhythm resynchronization. 
Altered circadian corticosterone activity and corticosterone levels in response to stress are in turn 
associated with disturbed circadian behavioral cycles, including sleep abnormalities (increased 
rapid eye movement [REM] sleep and sleep fragmentatio , decreased REM sleep latency, 
prolongation of the first REM sleep episode, diminished slow-wave sleep, and increased amount of 















among other, with an underlying dysfunction of the circadian clock, which results in abnormal 
circadian and sleep functions. 
 
Alternative mechanisms to explain these associations include epigenetic and inflammatory 
mechanisms [59,60], along with a shared genetic background between the examined traits (given 
that altered sleep is a well-known symptom of depression). For example, maternal depression 
during pregnancy is associated with epigenetic modifications of the GR gene in the placenta and 
fetal cord blood DNA [61], and recent studies have found altered methylation of inflammatory and 
androgen receptor genes in children and adults with obstructive sleep apnea [62,63], as well as 
different DNA methylation of genes related to cell adhesion processes and calcium ion binding in 
relation to different diurnal preference in monozygotic twins [64]. On the other hand, maternal 
depressive symptoms are associated with inflammation nd oxidative stress biomarkers in animal 
and human studies [65,66] and in utero exposure to inflammatory state is related to impaired 
circadian rhythms, altered sleep architecture, and sleep problems in the offspring [59,67]. It is 
likewise possible that socio-cultural factors contribute to our findings. Mothers who are depressed 
during and after pregnancy may themselves have disturbed sleep−wake rhythms, or may experience 
dysfunctional cognitions and perceptions about both infant sleep and their own capacity to 
answering the child’s needs, including sleep-related ones [28,68]. Further studies are needed to 
elucidate these possible mechanisms. 
 
Strengths of our study include a large sample size and the prospective study design with repeated 
measures of maternal depressive symptoms during pregnancy and at the child follow-up, and the 
use of different instruments to assess children’s sleep quantity, quality, and disorders from multiple 
perspectives. We were also able to account for a number of important covariates in our analyses, 















and pre-pregnancy disorders, smoking and alcohol use d ring pregnancy, parity, child gestational 
age, birth weight, age at follow-up, and weight-for-height SD score based on Finnish growth charts. 
We were also able to account for child’s psychiatric p oblems by conducting sensitivity analyses in 
which children with borderline clinically significant psychiatric problems were excluded. Finally, 
we were also able to account for depression-related bias in mother-reported child sleep. Although 
this is a strength, the fact that both maternal depressive symptoms and child sleep were rated by the 
mothers means that we cannot entirely rule out shared method variance and that child sleep 
problems may also be a stress factor that increases maternal depression. The latter, however, 
pertains to maternal depressive symptoms only afterpregnancy. 
 
This study also has a number of other limitations. Child sleep characteristics were all mother-rated. 
Even though these characteristics were measured using well-validated surveys, generalizations to 
objectively measured sleep duration, latency, and diagnosed sleep disorders cannot be made. 
Furthermore, even though we studied sleep characteristics in 2- to 6-year-old children, that is, when 
the sleep pattern is already fairly well consolidate , generalizations to younger and older study 
populations cannot be made either, and neither do these study findings generalize to other ethnic 
groups or cultures in which child sleep practices may differ. Importantly, we lacked data on paternal 
characteristics, including depressive symptoms, age, nd education level and occupation. Paternal 
depressive symptoms also predict child psychosocial development [69], and future studies are 
needed to compare the risks set forth on child sleep problems by maternal and paternal depressive 
symptoms, and to assess possible confounding by socioeconomic adversity more thoroughly, also 
taking paternal characteristics into account. Follow-up sample attrition was selective: the 
participating women were more educated, older, leaner in early pregnancy, and smoked less often 
during pregnancy. Our findings do not generalize to study populations that differ in these 















to rating the child sleep, a reverse causality (ie, child sleep characteristics contributing to maternal 
depressive symptoms) cannot be ruled out; thus, the results of our mediation analysis should be 
interpreted with caution. Finally, even though we could account for a number of maternal and child 
characteristics as covariates, we cannot rule out residual confounding. It is possible that maternal 
characteristics, including maternal depression, account for a tendency of the mothers to report 
depressive and sleep symptoms in their children. However, this seemed not to introduce any major 
bias in our study, as the six sleep domain scores were only moderately intercorrelated, and as only 
about one-fourth of the children were reported as having three or more co-occurring sleep disorders. 
Also, as depressed mothers by diagnostic definition suffer from sleep difficulties including 
insomnia [70], they may also be more aware of how their child sleeps and hence of the child’s sleep 
problems. Yet, also in this regard, it is important to note that maternal antenatal depressive 


















Maternal depressive symptoms throughout pregnancy, regardless of pregnancy stage, are associated 
with shorter sleep duration, longer latency, more frequent nocturnal awakenings, and increased risk 
for sleep disorders in children. Associations with child sleep duration and nocturnal awakenings are 
not specific to the prenatal period, whereas those with child sleep latency and disorders are. 
Maternal depressive symptoms at child follow-up partially mediated and added to the adverse 
effects of prenatal depressive symptoms on child sleep disorders. Interventions for preventing and 
alleviating depressive symptoms already during pregnancy may have long-term beneficial impact 
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Fig. 1. Latent profiles of maternal depressive symptoms during pregnancy. 
 
Fig. 2. Proportion of children with no, one, and two or more nocturnal awakenings according to 
maternal depressive symptoms latent profile groups during pregnancy. Numbers represent odds 
ratios (95% confidence interval) of having one and two or more nocturnal awakenings for children 
of mothers with subthreshold vs low and clinically significant vs low depressive symptoms during 
pregnancy. Model a refers to adjustments for child’s age and sex. Model b refers to model a 
adjustments + maternal age, educational attainment, pari y, early-pregnancy body mass index, 
hypertensive and diabetic pregnancy and pre-pregnancy disorders, smoking and alcohol use during 
pregnancy, and child’s gestational age and birth weight. Model c refers to model b adjustments + 
child’s weight-for-height SD score specific for the child’s age and sex according to Finnish growth 
charts. Model d refers to model b adjustments + matern l depressive symptoms at the time of rating 
the child sleep. 
 
Fig. 3. Proportion of children with sleep disorders according to maternal depressive symptoms 
latent profile groups during pregnancy. Numbers represent odds ratios (95% confidence interval) of 
having a sleep disorder (≥85th percentile) for children of mothers with subthreshold vs low and 
clinically significant vs low depressive symptoms during pregnancy. Model a refers to adjustments 
for child’s age and sex. Model b refers to model a adjustments + maternal age, educational 
attainment, parity, early-pregnancy body mass index, hypertensive and diabetic pregnancy and pre-
pregnancy disorders, smoking and alcohol use during pre nancy, and child’s gestational age and 
birth weight. Model c refers to model b adjustments + child’s weight-for-height SD score specific 
for the child’s age and sex according to Finnish growth charts. Model d refers to model b 















Fig. 4. Means and standard errors of child nocturnal sleep duration (panel A) and proportions and 
95% confidence intervals of child sleep disorders (panel B) according to maternal depressive 
symptoms during pregnancy (mean score above and below the clinical cutoff of 16 on the Center 
for Epidemiologic Studies Depression Scale [CES-D]) and after pregnancy (mean score above and 
below the clinical cutoff of 14 on the Beck Depression Inventory−II [BDI-II]). p Values for the 
interaction term are from fully adjusted models (contr lled for child’s age and sex, maternal age, 
educational attainment, parity, early pregnancy body mass index, pregnancy conditions, smoking, 
alcohol, child’s gestational age and birth weight, and maternal depression at follow-up). 
 
Figure S1. Mediation analyses. Associations between maternal depressive symptoms during 
pregnancy (trimester-weighted mean score on the Center for Epidemiologic Studies Depression 
Scale [CES-D]), maternal depressive symptoms at the time of rating the child sleep (Beck 
Depression Inventory−II sum score) and child nocturnal sleep duration (panel A), sleep latency 
(panel B), nocturnal awakenings (two or more) (panel C), and total sleep disorders (panel D). 
Numbers represent unstandardized coefficients, 95% confidence intervals, and p values adjusted for 

















Characteristics of the participants.  
  
Pregnancy and birth (n = 2321)  
Maternal characteristics  
Educational attainment  
Primary or secondary 866 (37.3) 
Lower tertiary 626 (27.0) 
Upper tertiary 829 (35.7) 
Age at delivery (y) 31.9 (4.6) 
Early-pregnancy body mass index (kg/m2) 24.3 (4.9) 
Primiparous (yes) (n = 2316) 972 (42.0%) 
Alcohol use during pregnancy (yes) (n = 2300) 379 (16.5%) 
Smoking during pregnancy  
No 2181 (94.0%) 
Quit during first trimester 75 (3.2%) 
Smoking throughout pregnancy 65 (2.8%) 
Any diabetic (gestational diabetes, type 1 diabetes) or hypertensive 
(chronic hypertension, gestational hypertension, preeclampsia) 
Pregnancy and pre-pregnancy disorders (yes) 
455 (19.6%) 
Center for Epidemiological Studies Depression Scale score  
Trimester 1 (n = 2217) 11.4 (7.9) 
Trimester 2 (n = 2313) 11.0 (6.5) 
Trimester 3 (n = 2255) 11.8 (7.2) 
Trimester-weighted mean 11.4 (6.4) 
Sex (male) 1177 (50.7%) 
Birth weight (g) 3521 (512.2) 
Gestational age (wk) 39.9 (1.6) 
Follow-up at 3.5 y  
Maternal characteristics  
Beck Depression Inventory−II score (n = 2289) 6.4 (6.3) 
Child characteristics  













Weight for height SD (n = 1869) 0.01 (1.0) 
Total psychiatric problems (n = 2296)  
Borderline  183 (8.0%) 
Child sleep characteristics  
Sleep duration/night (h) (n = 2276) 10.2 (0.8) 
Sleep latency (min) (n = 2274) 21.6 (15.1) 
Number of awakenings (n = 2247)  
None 883 (39.3%) 
1 1059 (47.1%) 
≥2 305 (13.6%) 
Sleep disorders (yes; ≥85th percentile)  
Total sleep disorders (n = 2320) 353 (15.2%) 
Disorders of initiating and maintaining sleep (n = 2306) 510 (22.1%) 
Arousal disorders (n = 2313) 624 (27.0%) 
Sleep breathing disorder (n = 2303) 373 (16.2%) 
Sleep−wake transition disorder (n = 2306) 411 (17.8%) 
Daytime excessive somnolence (n = 2313) 466 (20.2%) 
Sleep hyperhidrosis (n = 2306) 508 (22.0%) 
Means and standard deviations are given for continuous variables, and frequencies and percentages 


















Child sleep duration and sleep latency according to maternal depressive symptoms latent profile groups 
during pregnancy.  
 Sleep duration Sleep latency 
 
Subthreshold vs low maternal depressive symptoms 
B (95% CI) B (95% CI) 
Model a a –0.03 (–0.12 to 0.05) 0.39 (0.26 to 0.52) 
Model b b –0.04 (–0.13 to 0.05) 0.38 (0.25 to 0.52) 
Model c c –0.01 (–0.10 to 0.09) 0.43 (0.28 to 0.58) 
Model d d 0.00 (–0.09 to 0.09) 0.29 (0.15 to 0.43) 
Clinically significant vs low maternal depressive 
symptoms during pregnancy 
B (95% CI)a B (95% CI) a 
Model a a –0.20 (–0.33 to –0.07) 0.14 (0.06 to 0.23) 
Model b b –0.22 (–0.36 to –0.09) 0.15 (0.06 to 0.24) 
Model c c –0.19 (–0.34 to –0.04) 0.15 (0.05 to 0.24) 
Model d d –0.14 (–0.28 to 0.00) 0.10 (0.01 to 0.19) 
Unstandardized regression coefficients (B) and 95% confidence intervals (CI), indicating adjusted 
mean differences in standard deviation units in sleep duration and sleep latency between children of 
mothers with subthreshold vs low and clinically significant vs low depressive symptoms during 
pregnancy. All dependent variables are expressed in standard deviation units. 
 
a Model a is adjusted for child’s age and sex.  
b Model b is adjusted for model a covariates + maternl age, educational attainment, parity, early 
pregnancy body mass index, hypertensive and diabetic pregnancy and pre-pregnancy disorders, 
smoking and alcohol use during pregnancy, and child’s gestational age and birth weight.  
c Model c is adjusted for model b covariates + child’s weight-for-height SD score specific for the 
child’s age and sex according to Finnish growth charts.  
d Model d is adjusted for model b covariates and matern l depressive symptoms at the time of rating 
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Maternal prenatal depressive symptoms are associated with poor offspring sleep.  
 
It remains unknown whether these associations are specific to the pregnancy stage, and what role 
maternal depressive symptoms at the time of rating the child sleep play in these associations. 
 
In a prospective cohort of 2321 Finnish mother−child dyads, we found that 3.5-year-old children of 
women with clinically significant symptomatology throughout pregnancy had longer mother-rated 
sleep latency, higher odds of more frequent nighttime awakenings, and of total and a number of 
specific sleep disorders.  
 
These associations were not pregnancy stage specific.  
 
Maternal depressive symptoms at child follow-up partially or fully mediated these associations and 
added to the effects on child sleep disorders.  
 
These findings emphasize the importance of preventing and alleviating maternal depressive 
symptoms during pregnancy. 
 
